Jade Biosciences, Inc. (JBIO) financials · $868.2M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Jade Biosciences, Inc. (JBIO) $868.2M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$113.5M | -$35.5M |
| Net Income | -$127.4M | -$47.0M |
| EPS (Diluted) | -$3.19 | -$14.89 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $349.8M | $80.3M |
| Current Assets | $348.8M | $80.1M |
| Cash & Equivalents | $88.4M | $33.8M |
| PP&E | $170.0K | $6.00K |
| Total Liabilities | $17.3M | $3.90M |
| Current Liabilities | $16.5M | $3.83M |
| Shareholders' Equity | $332.5M | $76.4M |
| Retained Earnings | -$174.4M | -$233.1M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$94.7M | -$22.6M |
| CapEx | $196.0K | N/A |
| Investing Cash Flow | -$247.0M | N/A |
| Financing Cash Flow | $360.8M | $92.0M |
| Net Change in Cash | $19.1M | $69.4M |
| Free Cash Flow | -$94.9M | N/A |
FAQ
What is JBIO P/E and revenue?
Jade Biosciences, Inc. (JBIO) $868.2M cap.
What is JBIO revenue?
JBIO income-statement cache has no revenue figure yet.
Is JBIO profitable?
Jade Biosciences, Inc. last cached net income is -$127.4M (FY2025).
What are JBIO total assets?
Jade Biosciences, Inc. last cached total assets are $349.8M (FY2025).
What is JBIO free cash flow?
Jade Biosciences, Inc. last cached free cash flow is -$94.9M (FY2025).
Not investment advice. Cached statements, not a live tape.